B Riley Conference. B Riley Securities’ Virtual Neuroscience Conference will be hosted by our equity research team and feature fireside chats presentations and select 1×1 discussions hitting on key topics across neurodegeneration neuropsychiatry and mental health disease areas with both public and private healthcare companies The conference will also feature KOL panel discussions with academic.
Event B Riley Securities Crypto Conference Date Wednesday December 8 2021 Format Fireside chat and oneonone meetings Replay To be made available following the event and access posted.
VBI Vaccines to Participate in the B. Riley Securities
Details of the presentation can be found below B Riley Securities 2022 Oncology Conference Presentation Date January 28 2022 Presentation Time 200.
GT Biopharma to Present at B. Riley Securities' Virtual
For additional information regarding the conference please contact B Riley at events@brileyfincom About GT Biopharma Inc.
B. Riley Securities Presents Oncology Investor Conference
Leap Therapeutics to Present at B Riley Securities Oncology Investor Conference PR Newswire CAMBRIDGE Mass Jan 24 2022 CAMBRIDGE Mass Jan 24 2022.
Events
B. Riley Financial Diversified Financial Services Platform
Conference on December 8 B. Riley to Host Live Crypto
at B. Riley Bitfarms to Present Securities Crypto
B Riley Files Prelim Prospectus on $1B FaZe Clan Deal
TG Therapeutics to Participate in the B. Riley Securities
B. Riley to Host Live Crypto Conference on December 8
TG Therapeutics rebounds as B. Riley defends after selloff
Bitfarms to Present at B. Riley Securities Crypto
Sierra Oncology to Present at B. Riley Securities Oncology
Events B. Riley Financial
B. Riley Neuroscience Conference Overview
Fusion Pharmaceuticals to B. Riley Present at the
Cardiff Oncology to Present at the B. Riley Securities
Bitfarms to Present Securities Crypto at B. Riley
Babcock & Wilcox Enterprises to Present at B. Riley
B. Riley & Co. Consumer Conference
20th Annual B. Riley FBR Investor Conference
Leap Therapeutics to Present at B. Riley Securities
PDS Biotechnology to Present at B. Riley Securities
Yesterday the CEO Michael Weiss made the disclosure at an investor conference organized by B Riley Securities However later in the day the analysts at the firm defended the stock noting that.